Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: July 2011

Chapter 10 - Cerebral microbleeds in relation to cerebrovasculardisease

from Section 3 - Microbleeds in relation to specific populations, diseases and neurological symptoms

Summary

Cerebral microbleeds (CMBs) are an increasingly common radiological finding in stroke, neurological and general medical practice. There are two published CMB rating scales that have been validated in hospital cohorts of stroke patients. The rating scales are the microbleed anatomical rating scale (MARS) and the brain observer micro bleed scale (BOMBS). This chapter considers the radiological criteria for defining CMBs and then discusses these standardized rating scales. The potential for automatically detecting and mapping CMBs in future is discussed briefly in the chapter. Mapping CMBs gives information on the burden of CMBs in different anatomical regions in the brain. Quantifying the number of CMBs may be relevant in exploring their relationship with other quantitative imaging or clinical data and for prognostic purposes. Although visual rating scales can improve the reliability of identifying and mapping CMBs, more sophisticated automated methods are under investigation.

References

1. KoenneckeHC. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 2006;66:165–71.
2. RoobG, SchmidtR, KapellerPet al. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 1999;52:991–4.
3. KinoshitaT, OkuderaT, TamuraH, OgawaT, HatazawaJ. Assessment of lacunar hemorrhage associated with hypertensive stroke by echo-planar gradient-echo T2*-weighted MRI. Stroke 2000;31:1646–50.
4. HoritaY, ImaizumiT, NiwaJet al.[Analysis of dot-like hemosiderin spots using brain dock system.] NoShinkei Geka 2003;31:263–7.
5. JeerakathilT, WolfPA, BeiserAet al. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham study. Stroke 2004;35:1831–5.
6. VernooijMW, van der LugtA, IkramMAet al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008;70:1208–14.
7. KatoH, IzumiyamaM, IzumiyamaK, TakahashiA, ItoyamaY. Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 2002;33:1536–40.
8. TsushimaY, AokiJ, EndoK. Brain microhemorrhages detected on T2*-weighted gradient-echo MR images. AJNR Am J Neuroradiol 2003;24:88–96.
9. HanyuH, TanakaY, ShimizuSet al. Cerebral microbleeds in Binswanger's disease: a gradient-echo T2*-weighted magnetic resonance imaging study. Neurosci Lett 2003;340:213–16.
10. FanYH, ZhangL, LamWW, MokVC, WongKS. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke 2003;34:2459–62.
11. LeeSH, KwonSJ, KimKS, YoonBW, RohJK. Cerebral microbleeds in patients with hypertensive stroke. Topographical distribution in the supratentorial area. J Neurol 2004;251:1183–9.
12. LeeSH, BaeHJ, KwonSJet al. Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology 2004;62:72–6.
13. NakaH, NomuraE, WakabayashiSet al. Frequency of asymptomatic microbleeds on T2*-weighted MR images of patients with recurrent stroke: association with combination of stroke subtypes and leukoaraiosis. AJNR Am J Neuroradiol 2004;25:714–19.
14. ImaizumiT, HoritaY, HashimotoY, NiwaJ. Dotlike hemosiderin spots on T2*-weighted magnetic resonance imaging as a predictor of stroke recurrence: a prospective study. J Neurosurg 2004;101:915–20.
15. SchonewilleWJ, SingerMB, AtlasSW, TuhrimS. The prevalence of microhemorrhage on gradient-echo magnetic resonance imaging in acute lacunar infarction. J Stroke Cerebrovasc Dis 2005;14:141–4.
16. WerringDJ, CowardLJ, LosseffNA, JagerHR, BrownMM. Cerebral microbleeds are common in ischemic stroke but rare in TIA. Neurology 2005;65:1914–18.
17. BoulangerJM, CouttsSB, EliasziwMet al. Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischemic stroke or transient ischemic attack. Stroke 2006;37:911–14.
18. OvbiageleB, SaverJL, SanossianNet al. Predictors of cerebral microbleeds in acute ischemic stroke and TIA patients. Cerebrovasc Dis 2006;22:378–83.
19. WardlawJM, LewisSC, KeirSL, DennisMS, ShenkinS. Cerebral microbleeds are associated with lacunar stroke defined clinically and radiologically, independently of white matter lesions. Stroke 2006;37:2633–6.
20. FiehlerJ, AlbersGW, BoulangerJMet al. Bleeding risk analysis in stroke imaging before thrombolysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke 2007;38:2738–44.
21. LeeSH, KangBS, KimN, RohJK. Does microbleed predict haemorrhagic transformation after acute atherothrombotic or cardioembolic stroke? J Neurol Neurosurg Psychiatry 2008;79:913–16.
22. SeoWK, LeeJM, ParkMH, ParkKW, LeeDH. Cerebral microbleeds are independently associated with arterial stiffness in stroke patients. Cerebrovasc Dis 2008;26:618–23.
23. ChoAH, LeeSB, HanSJet al. Impaired kidney function and cerebral microbleeds in patients with acute ischemic stroke. Neurology 2009;73:1645–8.
24. JeonSB, KwonSU, ChoAHet al. Rapid appearance of new cerebral microbleeds after acute ischemic stroke. Neurology 2009;73:1638–44.
25. RoobG, LechnerA, SchmidtRet al. Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke 2000;31:2665–9.
26. JeongSW, JungKH, ChuKet al. Clinical and radiologic differences between primary intracerebral hemorrhage with and without microbleeds on gradient-echo magnetic resonance images. Arch Neurol 2004;61:905–9.
27. LeeSH, HeoJH, YoonBW. Effects of microbleeds on hemorrhage development in leukoaraiosis patients. Hypertens Res 2005;28:895–9.
28. GornerA, LemmensR, SchrootenM, ThijsV. Is leukoaraiosis on CT an accurate surrogate marker for the presence of microbleeds in acute stroke patients? J Neurol 2007;254:284–9.
29. FazekasF, KleinertR, RoobGet al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999;20:637–42.
30. TanakaA, UenoY, NakayamaY, TakanoK, TakebayashiS. Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke 1999;30:1637–42.
31. GreenbergSM, EngJA, NingM, SmithEE, RosandJ. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004;35:1415–20.
32. JeonSB, KangDW, ChoAHet al. Initial microbleeds at MR imaging can predict recurrent intracerebral hemorrhage. J Neurol 2007;254:508–12.
33. KumarS, GoddeauRP, Jr., SelimMHet al. Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology 2010;74:893–9.
34. KatohM, YoshinoM, AsaokaKet al. A restricted subarachnoid hemorrhage in the cortical sulcus in cerebral amyloid angiopathy: could it be a warning sign? Surg Neurol 2007;68:457–60.
35. LeeSH, KwonSJ, KimKS, YoonBW, RohJK. Topographical distribution of pontocerebellar microbleeds. AJNR Am J Neuroradiol 2004;25:1337–41.
36. JeongJH, YoonSJ, KangSJ, ChoiKG, NaDL. Hypertensive pontine microhemorrhage. Stroke 2002;33:925–9.
37. GreenbergSM, FinklesteinSP, SchaeferPW. Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI. Neurology 1996;46:1751–4.
38. van den BoomR, BornebroekM, BehloulFet al. Microbleeds in hereditary cerebral hemorrhage with amyloidosis-Dutch type. Neurology 2005;64:1288–9.
39. KimM, BaeHJ, LeeJet al. ApoE epsilon2/epsilon4 polymorphism and cerebral microbleeds on gradient-echo MRI. Neurology 2005;65:1474–5.
40. LeeSH, KimSM, KimN, YoonBW, RohJK. Cortico-subcortical distribution of microbleeds is different between hypertension and cerebral amyloid angiopathy. J Neurol Sci. 2007;258:111–14.
41. RosandJ, MuzikanskyA, KumarAet al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol 2005;58:459–62.
42. LeeSH, BaeHJ, KoSBet al. Comparative analysis of the spatial distribution and severity of cerebral microbleeds and old lacunes. J Neurol Neurosurg Psychiatry 2004;75:423–7.
43. StaalsJ, van OostenbruggeRJ, KnottnerusILet al. Brain microbleeds relate to higher ambulatory blood pressure levels in first-ever lacunar stroke patients. Stroke 2009;40:3264–8.
44. ChenYF, ChangYY, LiuJSet al. Association between cerebral microbleeds and prior primary intracerebral hemorrhage in ischemic stroke patients. Clin Neurol Neurosurg 2008;110:988–91.
45. LeeSH, ParkJM, KwonSJet al. Left ventricular hypertrophy is associated with cerebral microbleeds in hypertensive patients. Neurology 2004;63:16–21.
46. ViswanathanA, ChabriatH. Cerebral microhemorrhage. Stroke 2006;37:550–5.
47. IsoH, JacobsDR, Jr., WentworthD, NeatonJD, CohenJD. Serum cholesterol levels and six-year mortality from stroke in 350 977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med 1989;320:904–10.
48. ReedDM. The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol 1990;131:579–88.
49. AmarencoP, BogousslavskyJ, CallahanA, 3rd et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549–59.
50. GoldsteinLB, AmarencoP, SzarekMet al. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008;70:2364–70.
51. KimBJ, LeeS-H, RyuW-Set al. Low level of low-density lipoprotein cholesterol increases hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism. Stroke 2009;40:1627–32.
52. LeeSH, BaeHJ, YoonBWet al. Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions. Stroke 2002;33:2845–9.
53. VernooijMW, HaagMD, van der LugtAet al. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol 2009;66:714–20.
54. NighoghossianN, HermierM, AdeleinePet al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke 2002;33:735–42.
55. HeoSH, LeeSH, KimBJ, KangBS, YoonBW. Does glycated hemoglobin have clinical significance in ischemic stroke patients? Clin Neurol Neurosurg 2010;112:98–102.
56. IsekiK, KinjoK, KimuraY, OsawaA, FukiyamaK. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 1993;44:1086–90.
57. O’RourkeMF, SafarME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005;46:200–4.
58. YokoyamaS, HiranoH, UomizuKet al. High incidence of microbleeds in hemodialysis patients detected by T2*-weighted gradient-echo magnetic resonance imaging. Neurol Med Chir (Tokyo) 2005;45:556–60; discussion 560.
59. WatanabeA. Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis. J Stroke Cerebrovasc Dis 2007;16:30–3.
60. ShimaH, IshimuraE, NaganumaTet al. Cerebral microbleeds in predialysis patients with chronic kidney disease. Nephrol Dial Transplant 2010;25:1554–9.
61. OvbiageleB, LiebeskindDS, PinedaS, SaverJL. Strong independent correlation of proteinuria with cerebral microbleeds in patients with stroke and transient ischemic attack. Arch Neurol 2010;67:45–50.
62. GregoireSM, BrownMM, KallisCet al. MRI detection of new microbleeds in patients with ischemic stroke: five-year cohort follow-up study. Stroke 2010;41:184–6.
63. LeeST, LeeSH, RohJK. Changes in cerebral microbleed numbers of stroke patients and their prognostic factors. Proceedings of the International Stroke Conference of the American Stroke Association, San Antonio, USA, 2010, p. 491.
64. LeeSH, KimBJ, RohJK. Silent microbleeds are associated with volume of primary intracerebral hemorrhage. Neurology 2006;66:430–2.
65. ImaizumiT, HonmaT, HoritaYet al. Hematoma size in deep intracerebral hemorrhage and its correlation with dot-like hemosiderin spots on gradient echo T2*-weighted MRI. J Neuroimaging 2006;16:236–42.
66. KidwellCS, SaverJL, VillablancaJPet al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 2002;33:95–8.
67. KimBJ, LeeSH. Silent microbleeds and hemorrhagic conversion of an embolic infarction. J Clin Neurol 2007;3:147–9.
68. VernooijMW, HeeringaJ, de JongGJ, van der LugtA, BretelerMMB. Cerebral microbleed preceding symptomatic intracerebral hemorrhage in a stroke-free person. Neurology 2009;72:763–5.
69. KimHS, LeeDH, RyuCWet al. Multiple cerebral microbleeds in hyperacute ischemic stroke: impact on prevalence and severity of early hemorrhagic transformation after thrombolytic treatment. AJR Am J Roentgenol 2006;186:1443–9.
70. KakudaW, ThijsVN, LansbergMGet al. Clinical importance of microbleeds in patients receiving iv thrombolysis. Neurology 2005;65:1175–8.
71. AtlasSW, MarkAS, GrossmanRI, GomoriJM. Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. Radiology 1988;168:803–7.
72. WongKS, MokV, LamWWMet al. Aspirin-associated intracerebral hemorrhage: clinical and radiologic features. Neurology 2000;54:2298–2301.
73. LeeSH, RyuWS, RohJK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology 2009;72:171–6.
74. OrkenDN, KenangilG, UysalE, FortaH. Cerebral microbleeds in ischemic stroke patients on warfarin treatment. Stroke 2009;40:3638–40.